Longzhen Cui
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Biochemistry top 10%
- Sulfur Compounds in Biology
Papers in
-
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 5
- Hematology 21
- Acute Myeloid Leukemia Research 16
- Multiple Myeloma Research and Treatments 6
- Co-authors
- Lin Fu (24 shared papers)Yan Liu (22 shared papers)Zhiheng Cheng (18 shared papers)Tingting Qian (20 shared papers)Yifan Pang (10 shared papers)Liang Quan (12 shared papers)Jinlong Shi (11 shared papers)Xiaoyan Ke (3 shared papers)
- Journals
- Cancer Gene Therapy (6 papers)The Pharmacogenomics Journal (3 papers)Frontiers in Oncology (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Longzhen Cui
29 papers receiving 611 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 260
- Biochemistry 82
- Hematology 114
- Molecular Biology 430
- Immunology 87
Countries citing papers authored by Longzhen Cui
This map shows the geographic impact of Longzhen Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longzhen Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longzhen Cui more than expected).
Fields of papers citing papers by Longzhen Cui
This network shows the impact of papers produced by Longzhen Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longzhen Cui. The network helps show where Longzhen Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Longzhen Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 161 | |
| 2 | 2017 | 107 | |
| 3 | 2018 | 41 | |
| 4 | 2019 | 27 | |
| 5 | 2019 | 27 | |
| 6 | 2019 | 24 | |
| 7 | 2019 | 20 | |
| 8 | 2018 | 20 | |
| 9 | 2019 | 19 | |
| 10 | 2018 | 19 | |
| 11 | 2021 | 18 | |
| 12 | 2019 | 14 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 12 | |
| 15 | 2022 | 12 | |
| 16 | Prognostic value of the PDLIM family in acute myeloid leukemia. | 2019 | 12 |
| 17 | 2017 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 8 | |
| 20 | 2019 | 8 |
About Longzhen Cui
Longzhen Cui is a scholar working on Molecular Biology, Hematology, Cancer Research, Immunology and Genetics, having authored 29 papers that have together received 614 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Epigenetics and DNA Methylation (6 papers), Multiple Myeloma Research and Treatments (6 papers), Ubiquitin and proteasome pathways (5 papers), MicroRNA in disease regulation (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (260 citations), Biochemistry (82 citations), Hematology (114 citations), Molecular Biology (430 citations) and Immunology (87 citations). Longzhen Cui has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Lin Fu, Yan Liu, Zhiheng Cheng, Tingting Qian, Yifan Pang, Liang Quan, Jinlong Shi, Xiaoyan Ke, Yifeng Dai and Hongyou Zhao. Their work appears in journals such as Cancer Gene Therapy, The Pharmacogenomics Journal, Frontiers in Oncology, Journal of Cellular and Molecular Medicine and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.